Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May;68 Suppl 2(Suppl 2):e28609.
doi: 10.1002/pbc.28609.

Quality assurance in radiation oncology

Thomas J FitzGerald  1 , David Followill  2 , Fran Laurie  1 , Tom Boterberg  3 , Richard Hanusik  1 , Sandra Kessel  1 , Kathryn Karolczuk  1 , Matthew Iandoli  1 , Kenneth Ulin  1 , Karen Morano  1 , Maryann Bishop-Jodoin  1 , Stephen Kry  2 , Jessica Lowenstein  2 , Andrea Molineu  2 , Janaki Moni  1 , M Giulia Cicchetti  1 , Fred Prior  4 , Joel Saltz  5 , Ashish Sharma  6 , Henry C Mandeville  7 , Valerie Bernier-Chastagner  8 , Geert Janssens  9
Affiliations
Review

Quality assurance in radiation oncology

Thomas J FitzGerald et al. Pediatr Blood Cancer. 2021 May.

Abstract

The Children's Oncology Group (COG) has a strong quality assurance (QA) program managed by the Imaging and Radiation Oncology Core (IROC). This program consists of credentialing centers and providing real-time management of each case for protocol compliant target definition and radiation delivery. In the International Society of Pediatric Oncology (SIOP), the lack of an available, reliable online data platform has been a challenge and the European Society for Paediatric Oncology (SIOPE) quality and excellence in radiotherapy and imaging for children and adolescents with cancer across Europe in clinical trials (QUARTET) program currently provides QA review for prospective clinical trials. The COG and SIOP are fully committed to a QA program that ensures uniform execution of protocol treatments and provides validity of the clinical data used for analysis.

Keywords: credentialing; quality assurance; radiation therapy.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement: The authors have no conflicts of interest.

Figures

Figure 1.
Figure 1.
Imaging and radiation therapy real time central reviews in COG AHOD0031 Copyright© FitzGerald TJ, Bishop-Jodoin M, Bosch WR, Curran WJ, Followill DS, Galvin JM, Hanusik R, King SR, Knopp MV, Laurie F, O’Meara E, Michalski JM, Saltz JH, Schnall MD, Schwartz L, Ulin K, Xiao Y, Urie M. Front Oncol. 2013;3:31. Doi: 10.3389/fonc.2013.00031. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in other forums, provided the original authors and source are credited and subject to any copyright notices concerning any third-party graphics etc.
Figure 2.
Figure 2.
IROC Houston anthropomorphic QA phantoms shipped for credentialing Image courtesy of David S. Followill, PhD; IROC Principal Investigator
Figure 3.
Figure 3.
Investigator use of the IROC RI database to review clinical trial data and imaging. Image courtesy of IROC RI.
See this image and copyright information in PMC

References

    1. Weiner M, Leventhal B, Brecher M, et al. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages MB, IIIA2, NIB, and IV Hodgkin’s disease in pediatric patients: a Pediatric Oncology Group study. J Clin Oncol 1997;15:2769–2779. - PubMed
    1. FitzGerald TJ, Urie M, Ulin K, et al., Processes for quality improvements in radiation oncology clinical trials. Int J Radiat Oncol Biol Phys 2008;71 :S76–S79. - PMC - PubMed
    1. FitzGerald TJ, Bishop-Jodoin M, Followill D, et al. Imaging and data acquisition in clinical trials for radiation therapy. Int J Radiat Oncol Biol Phys 2016;94:404–411. - PMC - PubMed
    1. FitzGerald TJ Bishop-Jodoin M, Bosch W, et al. Future vision for the quality assurance of oncology clinical trials. Front Oncol 2013;3:31. - PMC - PubMed
    1. Friedman D, Chen L, Wolden S, et al. Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk Hodgkin lymphoma: a report from the Children’s Oncology Group Study AHOD0031. J Clin Oncol 2014;32:3651–3658. - PMC - PubMed